MSB 1.02% 99.0¢ mesoblast limited

Most of you are very well educated and know all about this...

  1. 582 Posts.
    lightbulb Created with Sketch. 279
    Most of you are very well educated and know all about this awesome company that's doing absolutely amazing things
    that will change the game when it comes to healing certain chronic and debilitating diseases. However a lot of newcomers to msb share register the true potential of our portfolio of assets , patents and intellectual property, partnerships that are already in place some with huge prospects for substantial income streams ... imo Mesoblast is set to become the dominant player in the world of stem cell regenerative treatments and a formidable powerhouse mega biotech company ... Funny thing is, it is still very tightly held mostly here in Australia ... Ozi ozi ozi !!!

    There a catalyst moment coming very soon in fact more than one ... the next announcement which is to be made on 11/11 in Chicago ( might just be one of them ) but bIg pharma partnerships and regulatory approvals will be coming anytime soon for potential blockbuster treatments ...

    you must watch the video presentations posted by Roka recently titled 'Cell and Gene Meeting on the Mesa ' for an insight into how the company is positioned ... the dialogue by both presenters is impressive and wIll InstIll confIdence In upcomIng short term potentIal for any investor..

    BlInd Freddy can see that major partnershIps, regulatory approvals and major commercIIalIzatIon Is gettIng very close .

    thIs company Is not a trader ...Its a long term keeper ... gltah
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
99.0¢
Change
0.010(1.02%)
Mkt cap ! $1.130B
Open High Low Value Volume
99.5¢ $1.02 98.5¢ $5.507M 5.501M

Buyers (Bids)

No. Vol. Price($)
1 9996 99.0¢
 

Sellers (Offers)

Price($) Vol. No.
99.5¢ 18069 3
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.